Chemotherapy for Participants With Lymphoma

NCT00436280 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphoma, Large Cell, Diffuse

Interventions

DRUG: enzastaurin
DRUG: gemcitabine
DRUG: rituximab
DRUG: oxaliplatin

Sponsor

Eli Lilly and Company